Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

Scientists develop novel technology that uses CRISPR to map genetic mutations

Scientists develop novel technology that uses CRISPR to map genetic mutations

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

Researchers discover new way to target cancer without destroying healthy T-cells

Researchers discover new way to target cancer without destroying healthy T-cells

California cracks down on weed killer as lawsuits abound

California cracks down on weed killer as lawsuits abound

Adipocytes may reduce effectiveness of chemotherapeutic drug

Adipocytes may reduce effectiveness of chemotherapeutic drug

New category of immunotherapy appears safe to use in patients with both cancer and HIV

New category of immunotherapy appears safe to use in patients with both cancer and HIV

FDA grants accelerated approval to new treatment for mantle cell lymphoma

FDA grants accelerated approval to new treatment for mantle cell lymphoma

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Penn researchers provide new insights into how Notch drives growth of B-cell cancers

Penn researchers provide new insights into how Notch drives growth of B-cell cancers

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Amid for-profit surge, rural hospice has offered free care for 40 years

Amid for-profit surge, rural hospice has offered free care for 40 years

New CAR-T cell therapy offers effective option for certain blood cancer patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

Novel gene expression signature assay could help enhance lymphoma management

Novel gene expression signature assay could help enhance lymphoma management

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Existing drugs could help patients with rare form of bone cancer

Existing drugs could help patients with rare form of bone cancer

Researchers pinpoint genetic drivers of diffuse large B cell lymphoma

Researchers pinpoint genetic drivers of diffuse large B cell lymphoma

Study on cell stress response may hold promise for treating inflammation-related disorders

Study on cell stress response may hold promise for treating inflammation-related disorders

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

Tattoo ink from 15 years ago mimics lymph node cancer: Case study